FR EN
Imcheck Therapeutics

Imcheck Therapeutics

Next Generation Immune Modulators

Understanding the complexity of the immune response to tumors and identifying new biomarkers to predict patient benefit from new immunotherapies, requires multi-disciplinary and highly motivated candidates working in a collaborative environment. ImCheck is in the process of developing ambitious programs which build on dynamic exchanges between researchers of the Cancer Research Center of Marseille, clinicians of the Institut Paoli-Calmettes and its worldwide network.

Together, we share a wide-range of experience in immunity and cancer as well as in first-in class drug candidates’ development which are aimed at tackling new strategies and strengthening existing cancer treatments.

We are currently seeking exceptional talent to join our team.

Website Linked

Discover our job offers

View offer

Protein Science/Analytical Biochemistry (Senior) Scientist - CDI

Function : Recherche préclinique
Job starts : 27-02-2019

The Mission   The candidate will be responsible for: Assessing analytical protein technologies to validate the quality/purity of ImCheck's protein targets; Small scale mammalian antibody production...
View offer

Senior Scientist in Auto-immunity - CDI

Function : Recherche préclinique
Job starts : 27-02-2019

The Mission   The candidate will report to the CSO and will be responsible to: Develop lead molecules from discovery to late stage preclinical development and build ImCheck's pipeline in autoimmunity; Coordinate...
View offer

Antibody Engineering (Senior) Scientist - CDI

Function : Recherche préclinique
Job starts : 27-02-2019

Mission   The candidate will be responsible for: Antibody lead optimization; Bispecific antibody optimization; Humanization of therapeutic antibodies; Immunogenicity assessment of antibodies; Contributing...

Spontaneous application

No offer meets your profile today?
Send a spontaneous application directly to the company of your choice! It's easy and fast, just a few clicks..

Click here